T-CELL AND NEURONAL APOPTOSIS IN HIV INFECTION: IMPLICATIONS FOR THERAPEUTIC INTERVENTION
暂无分享,去创建一个
K. Khalili | S. Amini | J. Zagury | P. Katsikis | J. Rappaport | K. Reiss | E. Régulier | Emmanuel G. Régulier
[1] K. Hagino-Yamagishi,et al. [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.
[2] Neuroimmunomodulation , 2004 .
[3] Chaohong Sun,et al. Regulation of the Apaf-1/Caspase-9 Apoptosome by Caspase-3 and XIAP* , 2003, The Journal of Biological Chemistry.
[4] Glen S. Hatfield,et al. Tat-Neutralizing Antibodies in Vaccinated Macaques , 2003, Journal of Virology.
[5] J. Altman,et al. IL-15 enhances survival and function of HIV-specific CD8+ T cells. , 2003, Blood.
[6] C. Belka,et al. The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways , 2003, Oncogene.
[7] D. Watkins,et al. Prevention of Disease Induced by a Partially Heterologous AIDS Virus in Rhesus Monkeys by Using an Adjuvanted Multicomponent Protein Vaccine , 2003, Journal of Virology.
[8] K. Khalili,et al. Neuroprotective effects of IGF-I against TNFalpha-induced neuronal damage in HIV-associated dementia. , 2003, Virology.
[9] Qiang Zhou,et al. HIV‐1 Tat targets microtubules to induce apoptosis, a process promoted by the pro‐apoptotic Bcl‐2 relative Bim , 2002, The EMBO journal.
[10] A. Nath. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. , 2002, The Journal of infectious diseases.
[11] R. O'Connor,et al. Insulin‐like growth factor‐1 activates Akt and Jun N‐terminal kinases (JNKs) in promoting the survival of T lymphocytes , 2002, Immunology.
[12] P. Mulholland,et al. Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-d-aspartate receptor , 2002, Brain Research.
[13] D. Montefiori,et al. Vaccination of Macaques with Long-Standing SIVmac251 Infection Lowers the Viral Set Point After Cessation of Antiretroviral Therapy1 , 2002, The Journal of Immunology.
[14] M. Mattson,et al. Calcium Dysregulation and Neuronal Apoptosis by the HIV‐1 Proteins Tat and gp120 , 2002, Journal of acquired immune deficiency syndromes.
[15] Mark G. Lewis,et al. Immunogenicity of HIV-1 IIIB and SHIV 89.6P Tat and Tat toxoids in rhesus macaques: induction of humoral and cellular immune responses. , 2002, DNA and cell biology.
[16] D. Montefiori,et al. Crosslinked HIV-1 envelope–CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] C. Payá,et al. CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells , 2002, AIDS.
[18] D. Weiner,et al. Adenovirus encoding HIV-1 Vpr activates caspase 9 and induces apoptotic cell death in both p53 positive and negative human tumor cell lines , 2002, Oncogene.
[19] M. Lederman,et al. Short Communication: Effect of Etanercept (Enbrel) on Interleukin 6, Tumor Necrosis Factor α, and Markers of Immune Activation in HIV-Infected Subjects Receiving Interleukin 2 , 2002 .
[20] J. Cambier,et al. Ligation of human CD4 interferes with antigen-induced activation of primary T cells. , 2002, Immunology letters.
[21] Yili Yang,et al. HIV Tat Binds Egr Proteins and Enhances Egr-dependent Transactivation of the Fas Ligand Promoter* , 2002, The Journal of Biological Chemistry.
[22] Junying Yuan,et al. Caspase Cascades in Human Immunodeficiency Virus-Associated Neurodegeneration , 2002, The Journal of Neuroscience.
[23] J. Southgate,et al. Effects of insulin-like growth factors I and II on tumour-necrosis-factor-alpha-induced apoptosis in early murine embryos. , 2002, Reproduction, fertility, and development.
[24] Mark G. Lewis,et al. Outcome of Simian-Human Immunodeficiency Virus Strain 89.6p Challenge following Vaccination of Rhesus Macaques with Human Immunodeficiency Virus Tat Protein , 2002, Journal of Virology.
[25] Todd M. Allen,et al. Tat-Vaccinated Macaques Do Not Control Simian Immunodeficiency Virus SIVmac239 Replication , 2002, Journal of Virology.
[26] M. Mudryj,et al. Simian Immunodeficiency Virus Nef Protein Delays the Progression of CD4+ T Cells through G1/S Phase of the Cell Cycle , 2002, Journal of Virology.
[27] J. Mills,et al. Human Immunodeficiency Virus Type 1 Nef Binds to Tumor Suppressor p53 and Protects Cells against p53-Mediated Apoptosis , 2002, Journal of Virology.
[28] C. Rapp,et al. Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3. , 2002, Blood.
[29] J. Corbeil,et al. Productive HIV-1 Infection of Primary CD4+ T Cells Induces Mitochondrial Membrane Permeabilization Leading to a Caspase-independent Cell Death* , 2002, The Journal of Biological Chemistry.
[30] A. Giordano,et al. Functional interaction between cyclin T1/cdk9 and Purα determines the level of TNFα promoter activation by Tat in glial cells , 2001, Journal of Neuroimmunology.
[31] J. Altman,et al. Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells. , 2001, Immunity.
[32] Stephan Bour,et al. The Human Immunodeficiency Virus Type 1 Accessory Protein Vpu Induces Apoptosis by Suppressing the Nuclear Factor κB–dependent Expression of Antiapoptotic Factors , 2001, The Journal of experimental medicine.
[33] A. Schürmann,et al. HIV-1 Nef associated PAK and PI3-Kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals , 2001, Nature Medicine.
[34] Xavier Alvarez,et al. Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system , 2001, Glia.
[35] D. Noonan,et al. HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. , 2001, Biochemical and biophysical research communications.
[36] C. Hallahan,et al. CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients , 2001, AIDS.
[37] C. Petito,et al. Detection of HIV‐1 Gene Sequences in Hippocampal Neurons Isolated from Postmortem AIDS Brains by Laser Capture Microdissection , 2001, Journal of neuropathology and experimental neurology.
[38] S. Dewhurst,et al. Neurotrophins prevent HIV Tat‐induced neuronal apoptosis via a nuclear factor‐κB (NF‐κB)‐dependent mechanism , 2001 .
[39] V. Robert-Hebmann,et al. Binding of Human Immunodeficiency Virus Type 1 gp120 to CXCR4 Induces Mitochondrial Transmembrane Depolarization and Cytochromec-Mediated Apoptosis Independently of Fas Signaling , 2001, Journal of Virology.
[40] J. Brady,et al. HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells. , 2001, AIDS research and human retroviruses.
[41] M. Mattson,et al. HIV‐1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity , 2001, Journal of neurochemistry.
[42] N. Selliah,et al. HIV-1 NL4-3, but not IIIB, inhibits JAK3/STAT5 activation in CD4(+) T cells. , 2001, Virology.
[43] C. Lang,et al. Tissue-specific regulation of IGF-I and IGF-binding proteins in response to TNFα , 2001 .
[44] J. Tschopp,et al. NF-κB Signals Induce the Expression of c-FLIP , 2001, Molecular and Cellular Biology.
[45] M. Kitamura,et al. Expression, regulation, and function of inhibitor of apoptosis family genes in rat mesangial cells. , 2001, Kidney international.
[46] Y. Gu,et al. HIV Tat activates c-Jun amino-terminal kinase through an oxidant-dependent mechanism. , 2001, Virology.
[47] F. Peruzzi,et al. Anti-apoptotic Signaling of the Insulin-like Growth Factor-I Receptor through Mitochondrial Translocation of c-Raf and Nedd4* , 2001, The Journal of Biological Chemistry.
[48] L. Glimcher,et al. Tumor Necrosis Factor Receptor–Associated Factor (Traf)2 Represses the T Helper Cell Type 2 Response through Interaction with Nfat-Interacting Protein (Nip45) , 2001, The Journal of experimental medicine.
[49] Simon C Watkins,et al. Overexpression of tumor necrosis factor- alpha activates both anti- and pro-apoptotic pathways in the myocardium. , 2001, Journal of molecular and cellular cardiology.
[50] S. Croul,et al. Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas , 2001, Oncogene.
[51] R. Compans,et al. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. , 2001, Virology.
[52] P. Krammer,et al. The effect of HIV‐1 regulatory proteins on cellular genes: derepression of the IL‐2 promoter by Tat , 2001, European journal of immunology.
[53] S. Wesselingh,et al. Correlation between neurological progression and astrocyte apoptosis in HIV‐associated dementia , 2001, Annals of neurology.
[54] I. Hewlett,et al. Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat. , 2001, Journal of biomedical science.
[55] Stuart A. Lipton,et al. Pathways to neuronal injury and apoptosis in HIV-associated dementia , 2001, Nature.
[56] A. Lackner,et al. Perivascular Macrophages Are the Primary Cell Type Productively Infected by Simian Immunodeficiency Virus in the Brains of Macaques , 2001, The Journal of experimental medicine.
[57] W. Greene,et al. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell , 2001, Nature.
[58] E. Masliah,et al. Amelioration of Neurotoxic Effects of HIV Envelope Protein gp120 by Fibroblast Growth Factor: A Strategy for Neuroprotection , 2001, Journal of neuropathology and experimental neurology.
[59] S. Rowland-Jones,et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes , 2001, Nature.
[60] R. Locksley,et al. The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.
[61] F. Kashanchi,et al. Cell Cycle Regulation of Human Interleukin-8 Gene Expression by the Human Immunodeficiency Virus Type 1 Tat Protein , 2001, Journal of Virology.
[62] R. Mitsuyasu. The potential role of interleukin-2 in HIV , 2001, AIDS.
[63] Sunyoung Kim,et al. Brief Comment: Stable Expression of Human Immunodeficiency Virus Type 1 Nef Confers Resistance against Fas-Mediated Apoptosis , 2001 .
[64] C. Payá,et al. Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes. , 2001, The Journal of clinical investigation.
[65] G. Shulman,et al. Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. , 2001, The Journal of clinical investigation.
[66] J. Groopman,et al. HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes. , 2001, Blood.
[67] G. Robichaud,et al. HIV type 1 nef gene inhibits tumor necrosis factor alpha-induced apoptosis and promotes cell proliferation through the action of MAPK and JNK in human glial cells. , 2000, AIDS research and human retroviruses.
[68] W. Fiers,et al. Structure/Function Analysis of p55 Tumor Necrosis Factor Receptor and Fas-associated Death Domain , 2000, The Journal of Biological Chemistry.
[69] R. Tanzi,et al. Uptake of HIV-1 Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands , 2000, Nature Medicine.
[70] M. Benkirane,et al. Tat Protein of Human Immunodeficiency Virus Type 1 Induces Interleukin-10 in Human Peripheral Blood Monocytes: Implication of Protein Kinase C-Dependent Pathway , 2000, Journal of Virology.
[71] H. Xiao,et al. Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[72] A. Bansal,et al. Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum , 2000, Brain Research.
[73] W. Marasco,et al. Grb3-3 Is Up-regulated in HIV-1-infected T-cells and Can Potentiate Cell Activation through NFATc* , 2000, The Journal of Biological Chemistry.
[74] O. Kutsch,et al. Induction of the Chemokines Interleukin-8 and IP-10 by Human Immunodeficiency Virus Type 1 Tat in Astrocytes , 2000, Journal of Virology.
[75] W. Marasco,et al. Upregulation of the apoptosis-associated protein Grb3-3 in HIV-1-infected human CD4(+) lymphocytes. , 2000, Biochemical and biophysical research communications.
[76] R. Testi,et al. Primary macrophages infected by human immunodeficiency virus trigger CD95‐mediated apoptosis of uninfected astrocytes , 2000, Journal of leukocyte biology.
[77] Y. Lau,et al. Insulin-Like Growth Factor 1 Promotes Cord Blood T Cell Maturation and Inhibits Its Spontaneous and Phytohemagglutinin-Induced Apoptosis Through Different Mechanisms1 , 2000, The Journal of Immunology.
[78] Avindra Nath,et al. Release of Calcium from Inositol 1,4,5-Trisphosphate Receptor-Regulated Stores by HIV-1 Tat Regulates TNF-α Production in Human Macrophages1 , 2000, The Journal of Immunology.
[79] S. Manna,et al. Differential Requirement for p56lck in HIV-tat Versus TNF-Induced Cellular Responses: Effects on NF-κB, Activator Protein-1, c-Jun N-Terminal Kinase, and Apoptosis1 , 2000, The Journal of Immunology.
[80] D. Noonan,et al. Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat. , 2000, Biochemical and biophysical research communications.
[81] R. O'Connor,et al. The insulin‐like growth factor‐I receptor is regulated by CD28 and protects activated T cells from apoptosis , 2000, European journal of immunology.
[82] A. Burny,et al. Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques , 2000 .
[83] E. Masliah,et al. Fibroblast growth factor modulates HIV coreceptor CXCR4 expression by neural cells , 2000 .
[84] P. Krammer,et al. T cell activation‐induced and HIV Tat‐enhanced CD95(APO‐1 / Fas) ligand transcription involves NF‐κB , 2000 .
[85] Melina V Jones,et al. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine , 2000, Annals of neurology.
[86] S. Gartner. HIV Infection and Dementia , 2000, Science.
[87] R. Cooney,et al. Tat mediates apoptosis in vivo in the rat central nervous system. , 2000, Biochemical and biophysical research communications.
[88] M. Mattson,et al. Activity‐Dependent Neurotrophic Factor Peptide (ADNF9) Protects Neurons Against Oxidative Stress‐Induced Death , 1999, Journal of neurochemistry.
[89] A. Nath,et al. Involvement of Inositol 1,4,5‐Trisphosphate‐Regulated Stores of Intracellular Calcium in Calcium Dysregulation and Neuron Cell Death Caused by HIV‐1 Protein Tat , 1999, Journal of neurochemistry.
[90] M. Giacca,et al. Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells. , 1999, AIDS.
[91] G. Barillari,et al. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor. , 1999, Blood.
[92] M. Mattson,et al. Evidence that Par-4 participates in the pathogenesis of HIV encephalitis. , 1999, The American journal of pathology.
[93] E. Major,et al. Transient Exposure to HIV-1 Tat Protein Results in Cytokine Production in Macrophages and Astrocytes , 1999, The Journal of Biological Chemistry.
[94] J. Heeney,et al. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine , 1999, Nature Medicine.
[95] G. Jansen,et al. Overexpression of nerve growth factor and basic fibroblast growth factor in AIDS dementia complex , 1999, Journal of Neuroimmunology.
[96] Chrétien,et al. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage , 1999, Neuropathology and applied neurobiology.
[97] S. Croul,et al. Molecular pathway involved in HIV‐1‐induced CNS pathology: role of viral regulatory protein, Tat , 1999, Journal of leukocyte biology.
[98] S. Bartz,et al. Human Immunodeficiency Virus Type 1 Tat Induces Apoptosis and Increases Sensitivity to Apoptotic Signals by Up-Regulating FLICE/Caspase-8 , 1999, Journal of Virology.
[99] D. Olive,et al. Human Immunodeficiency Virus Type 1 Nef Protein Sensitizes CD4+ T Lymphoid Cells to Apoptosis via Functional Upregulation of the CD95/CD95 Ligand Pathway , 1999 .
[100] R. Osathanondh,et al. Apoptosis Induced by Infection of Primary Brain Cultures with Diverse Human Immunodeficiency Virus Type 1 Isolates: Evidence for a Role of the Envelope , 1999, Journal of Virology.
[101] M. Mattson,et al. Pivotal Role of Mitochondrial Calcium Uptake in Neural Cell Apoptosis and Necrosis , 1999, Journal of neurochemistry.
[102] F. Silverstein,et al. Tat, a human immunodeficiency virus-1 derived protein, augments excitotoxic hippocampal injury in neonatal rats , 1999, Neuroscience.
[103] Carolyn R. Casella,et al. Vpu Increases Susceptibility of Human Immunodeficiency Virus Type 1-Infected Cells to Fas Killing , 1999, Journal of Virology.
[104] G. Haegeman,et al. Activation of p42/p44 mitogen‐activated protein kinases (MAPK) and p38 MAPK by tumor necrosis factor (TNF) is mediated through the death domain of the 55‐kDa TNF receptor , 1998, FEBS letters.
[105] M. Mattson,et al. HIV-1 Protein Tat Induces Apoptosis of Hippocampal Neurons by a Mechanism Involving Caspase Activation, Calcium Overload, and Oxidative Stress , 1998, Experimental Neurology.
[106] A. Rice,et al. Tat-Associated Kinase, TAK, Activity Is Regulated by Distinct Mechanisms in Peripheral Blood Lymphocytes and Promonocytic Cell Lines , 1998, Journal of Virology.
[107] K. Khalili,et al. Structure and function of HIV-1 and SIV Tat proteins based on carboxy-terminal truncations, chimeric Tat constructs, and NMR modeling. , 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[108] John Calvin Reed,et al. Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.
[109] Irene Bosch,et al. Tat Protein Induces Human Immunodeficiency Virus Type 1 (HIV-1) Coreceptors and Promotes Infection with both Macrophage-Tropic and T-Lymphotropic HIV-1 Strains , 1998, Journal of Virology.
[110] Guoji Wang,et al. Expression of brain‐derived neurotrophic factor protein in activated microglia of human immunodeficiency virus type 1 encephalitis , 1998, Neuropathology and applied neurobiology.
[111] R. Rabin,et al. HIV-1 Tat protein mimicry of chemokines. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[112] G. Natoli,et al. Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling. , 1998, Biochemical pharmacology.
[113] R. Bailey,et al. Insulin-like growth factor-I resistance. , 1998, Endocrine reviews.
[114] B. Peterlin,et al. The Ability of Positive Transcription Elongation Factor b To Transactivate Human Immunodeficiency Virus Transcription Depends on a Functional Kinase Domain, Cyclin T1, and Tat , 1998, Journal of Virology.
[115] J. Kyriakis,et al. Tumor Necrosis Factor Signaling to Stress-activated Protein Kinase (SAPK)/Jun NH2-terminal Kinase (JNK) and p38 , 1998, The Journal of Biological Chemistry.
[116] A. Nath,et al. HIV-1 Tat Molecular Diversity and Induction of TNF-α: Implications for HIV-Induced Neurological Disease , 1998, Neuroimmunomodulation.
[117] S. Manna,et al. HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. , 1998, Journal of immunology.
[118] L. Epstein,et al. HIV-1 Tat Induces Neuronal Death via Tumor Necrosis Factor-α and Activation of Non-N-methyl-d-aspartate Receptors by a NFκB-Independent Mechanism* , 1998, The Journal of Biological Chemistry.
[119] J. Brady,et al. Regulation of TNFα and TGFβ-1 gene transcription by HIV-1 Tat in CNS cells , 1998, Journal of Neuroimmunology.
[120] R. Zidovetzki,et al. Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase C- and cAMP-dependent protein kinase pathways. , 1998, AIDS research and human retroviruses.
[121] C. Payá,et al. The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection. , 1998, The Journal of clinical investigation.
[122] W. Blattner,et al. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. , 1998, Journal of human virology.
[123] E. Major,et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[124] A. Lazzarin,et al. Cerebrospinal fluid HIV‐1 RNA levels: correlation with HIV encephalitis , 1998, AIDS.
[125] Ping Wei,et al. A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.
[126] C. Tacchetti,et al. Monocyte‐derived dendritic cells and monocytes migrate to HIV‐Tat RGD and basic peptides , 1998, AIDS.
[127] M. Mattson,et al. Calcium and reactive oxygen species mediate staurosporine‐induced mitochondrial dysfunction and apoptosis in PC12 cells , 1998, Journal of neuroscience research.
[128] T. Jernigan,et al. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. , 1998, Archives of neurology.
[129] A. Nath,et al. Neurobiological aspects of human immunodeficiency virus infection:Neurotoxic mechanisms , 1998, Progress in Neurobiology.
[130] S. Korsmeyer,et al. A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis , 1997, Journal of virology.
[131] J. McArthur,et al. Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain , 1997, Annals of neurology.
[132] J. Torres-Roca,et al. Interleukin-1β Converting Enzyme–like Protease Involvement in Fas-induced and Activation-induced Peripheral Blood T Cell Apoptosis in HIV Infection. TNF-related Apoptosis-inducing Ligand Can Mediate Activation-induced T Cell Death in HIV Infection , 1997, The Journal of experimental medicine.
[133] D. Hazuda,et al. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. , 1997, Genes & development.
[134] M. Mathews,et al. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. , 1997, Genes & development.
[135] Luigi Buonaguro,et al. HIV‐1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix‐associated heparan sulfate proteoglycans through its basic region , 1997, AIDS.
[136] S. Hochman,et al. Neuronal excitatory properties of human immunodeficiency virus type 1 tat protein , 1997, Neuroscience.
[137] A. Nath,et al. The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. , 1997, The Journal of biological chemistry.
[138] J. Meldolesi,et al. HIV‐1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid , 1997, FEBS letters.
[139] C. Ambrosino,et al. HIV-1 Tat Induces the Expression of the Interleukin-6 (IL6) Gene by Binding to the IL6 Leader RNA and by Interacting with CAAT Enhancer-binding Protein β (NF-IL6) Transcription Factors* , 1997, The Journal of Biological Chemistry.
[140] M. McGrath,et al. Unique monocyte subset in patients with AIDS dementia , 1997, The Lancet.
[141] Y. Adachi,et al. Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection. , 1997, Journal of immunology.
[142] N. Young,et al. Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication. , 1997, Blood.
[143] H. Wiśniewski,et al. Microencephaly in children congenitally infected with human immunodeficiency virus – a gross-anatomical morphometric study , 1997, Acta Neuropathologica.
[144] E. Verdin,et al. Dual role of HIV Tat in regulation of apoptosis in T cells. , 1997, Journal of immunology.
[145] M. Colombo,et al. Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T-cell clones with different T-helper phenotypes: role of CD95/CD95L interactions. , 1997, Blood.
[146] J. Xiang,et al. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[147] Elizabeth Yang,et al. Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.
[148] J S Beckman,et al. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.
[149] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[150] S. Lipton. Similarity of Neuronal Cell Injury and Death in AIDS Dementia and Focal Cerebral Ischemia: Potential Treatment with NMDA Open‐Channel Blockers and Nitric Oxide‐Related Species , 1996, Brain pathology.
[151] I. Herr,et al. Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis , 1996, Journal of virology.
[152] C. Smith,et al. Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals. , 1996, International immunology.
[153] O. Meucci,et al. gp120-Induced Neurotoxicity in Hippocampal Pyramidal Neuron Cultures: Protective Action of TGF-β1 , 1996, The Journal of Neuroscience.
[154] M. Giacca,et al. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1 , 1996, Journal of virology.
[155] S. Nagata,et al. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. , 1996, Blood.
[156] K. Khalili,et al. Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[157] G. Nuovo,et al. AIDS Dementia Is Associated with Massive, Activated HIV-1 Infection and Concomitant Expression of Several Cytokines , 1996, Molecular medicine.
[158] D. Tenen,et al. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter , 1996, Molecular and cellular biology.
[159] D. Magnuson,et al. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic , 1996, Journal of virology.
[160] E. Major,et al. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes , 1996, Journal of virology.
[161] B. Spiegelman,et al. IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.
[162] D. Fuchs,et al. Oxidative Stress and Apoptosis in HIV Infection , 1996, Science.
[163] Y. Ben-Ari,et al. The HIV‐1 envelope protein GP120 induces neuronal apoptosis in hippocampal slices , 1996, Neuroreport.
[164] L. Mucke,et al. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine , 1996, Brain Research.
[165] C. Payá,et al. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes , 1996, Journal of virology.
[166] S. Lipton,et al. The Coat Protein gp120 of HIV‐1 Inhibits Astrocyte Uptake of Excitatory Amino Acids via Macrophage Arachidonic Acid , 1995, The European journal of neuroscience.
[167] J. Glass,et al. Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia , 1995, Annals of neurology.
[168] G D Pearlson,et al. Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. , 1995, The American journal of psychiatry.
[169] M. Krönke,et al. TNF-induced activation of NF-kappa B. , 1995, Immunobiology.
[170] S. Rowland-Jones,et al. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[171] P. Krammer,et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 , 1995, Nature.
[172] G. Nisticó,et al. HIV-1 gp120 produces DNA fragmentation in the cerebral cortex of rat. , 1995, Biochemical and biophysical research communications.
[173] L. Epstein,et al. Apoptotic neurons in brains from paediatric patients with HIV‐I encephalitis and progressive encephalopathy , 1995, Neuropathology and applied neurobiology.
[174] Christine A. Lee,et al. Presence of CD3+CD8+Bcl-2(low) lymphocytes undergoing apoptosis and activated macrophages in lymph nodes of HIV-1+ patients. , 1995, The American journal of pathology.
[175] L. Herzenberg,et al. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals , 1995, The Journal of experimental medicine.
[176] Y. Lévy,et al. Neuronal apoptosis in HIV infection in adults , 1995, Neuropathology and applied neurobiology.
[177] A. Fauci,et al. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. , 1995, Journal of immunology.
[178] V. Metelev,et al. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. , 1995, Science.
[179] M E Greenberg,et al. Calcium signaling in neurons: molecular mechanisms and cellular consequences. , 1995, Science.
[180] Howard E. Gendelman,et al. Dementia Associated with the Acquired Immunodeficiency Syndrome , 1995 .
[181] G. Pavlakis,et al. Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function , 1995, Journal of virology.
[182] R. Brownstone,et al. Human immunodeficiency virus type 1 tat activates non—N‐methyl‐D‐aspartate excitatory amino acid receptors and causes neurotoxicity , 1995, Annals of neurology.
[183] T. Curiel,et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes , 1995, Nature Medicine.
[184] G. Arbuthnott,et al. The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. , 1994, Virology.
[185] M. Dohadwala,et al. Exogenous tat protein activates central nervous system-derived endothelial cells , 1994, Journal of Neuroimmunology.
[186] B. Tavolato,et al. Cerebrospinal fluid analysis in HIV‐1‐infected children: immunological and virological findings before and after AZT therapy , 1994, Acta paediatrica.
[187] F. Barré-Sinoussi,et al. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[188] M. Baer,et al. C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[189] L. Mucke,et al. Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice , 1994, Nature.
[190] S. D’Mello,et al. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[191] J. Becker,et al. Dementia in AIDS patients , 1993, Neurology.
[192] O. Selnes,et al. Clinical‐neuropathologic correlation in HIV‐associated dementia , 1993, Neurology.
[193] S. Capitani,et al. Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. , 1993, Cancer research.
[194] G. D. Pearlson,et al. Reduced basal ganglia volume in HIV‐1‐associated dementia , 1993, Neurology.
[195] K. Khalili,et al. Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS. , 1993, Oncogene.
[196] C. Debouck,et al. HIV-1 Tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. , 1993, AIDS research and human retroviruses.
[197] J. Glass,et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dememtia , 1993, Annals of neurology.
[198] J. Heeney,et al. Programmed cell death in AIDS-related HIV and SIV infections. , 1993, AIDS research and human retroviruses.
[199] S. Snyder,et al. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[200] E. Ruoslahti,et al. A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin , 1993, The Journal of cell biology.
[201] D. Giulian,et al. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[202] H. Kleinman,et al. Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein. , 1993, The Journal of biological chemistry.
[203] S. Lipton. Human immunodefciency virus‐infected macrophages, gp120, and N‐methyl‐D‐ aspartate receptor‐mediated new‐otoxicity , 1993 .
[204] P. Wingfield,et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation , 1993, Journal of virology.
[205] G. Zauli,et al. tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. , 1992, Blood.
[206] O. Bagasra,et al. TAR-independent replication of human immunodeficiency virus type 1 in glial cells , 1992, Journal of virology.
[207] M. Tsang,et al. Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity. Implications in neuronal injury. , 1992, The Journal of clinical investigation.
[208] F. Miedema,et al. Programmed death of T cells in HIV-1 infection. , 1992, Science.
[209] P. Carrieri,et al. Cerebrospinal fluid cytokines in AIDS dementia complex , 1992, Journal of Neurology.
[210] J. Bormann,et al. gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. , 1992, European journal of pharmacology.
[211] L. Montagnier,et al. Human immunodeficiency virus type 1–infected monocytic cells can destroy human neural cells after cell‐to‐cell adhesion , 1992, Annals of neurology.
[212] J. Glass,et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome , 1992, Annals of neurology.
[213] A. Capron,et al. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals , 1992, The Journal of experimental medicine.
[214] P. Gluckman,et al. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. , 1992, Biochemical and biophysical research communications.
[215] S. Akira,et al. Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. , 1992, Blood.
[216] J. Merrill,et al. HIV‐1, macrophages, glial cells, and cytokines in AIDS nervous system disease , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[217] B. Tavolato,et al. Immunological Markers in the Cerebrospinal Fluid of HIV‐1‐Infected Children , 1991, Acta paediatrica Scandinavica.
[218] E. Masliah,et al. Neocortical damage during HIV infection , 1991, Annals of neurology.
[219] E. Vivés,et al. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1 , 1991 .
[220] D. Giulian,et al. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1 , 1990, Science.
[221] F. Chiodi,et al. Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system. , 1990, Clinical immunology and immunopathology.
[222] K. Butler,et al. Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndrome. , 1990, The Journal of pediatrics.
[223] C. Debouck,et al. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type 1 transactivation protein, tat , 1990, The Journal of cell biology.
[224] S. Salahuddin,et al. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients , 1990, Nature.
[225] M. Katze,et al. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. , 1990, Science.
[226] A. Fauci,et al. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[227] K. Frei,et al. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid , 1989, Journal of Neuroimmunology.
[228] P. Sperryn,et al. Blood. , 1989, British journal of sports medicine.
[229] S. Orrenius,et al. Calcium-activated DNA fragmentation in rat liver nuclei. , 1989, The Journal of biological chemistry.
[230] G. Nabel,et al. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[231] Carl O. Pabo,et al. Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.
[232] M. Hirsch,et al. Neurologic manifestations of infection with human immunodeficiency virus. Clinical features and pathogenesis. , 1987, Annals of internal medicine.
[233] H. Budka,et al. Brain pathology induced by infection with the human immunodeficiency virus (HIV) , 1987, Acta Neuropathologica.
[234] B. Navia,et al. The AIDS dementia complex: II. Neuropathology , 1986, Annals of neurology.
[235] R. Kapila,et al. Neuropathologic observations in acquired immunodeficiency syndrome (AIDS) , 1985, Acta Neuropathologica.
[236] C. Petito,et al. Subacute encephalitis in acquired immune deficiency syndrome: a postmortem study. , 1984, American journal of clinical pathology.
[237] J. Cohen,et al. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. , 1984, Journal of immunology.
[238] Manjit,et al. Neurology , 1912, NeuroImage.
[239] L. Wilkinson. Immunity , 1891, The Lancet.
[240] Neil Genzlinger. A. and Q , 2006 .
[241] H. Budka,et al. Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study , 2004, Acta Neuropathologica.
[242] P. Katsikis,et al. IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells. , 2003, International immunology.
[243] K. Khalili,et al. Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[244] J. Kim,et al. HIV-1 viral protein R compromises cellular immune function in vivo. , 2002, International immunology.
[245] W. Blattner,et al. Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments. , 2002, Journal of human virology.
[246] U. Dianzani,et al. Decreased function of Fas in patients displaying delayed progression of HIV-induced immune deficiency. , 2001, The hematology journal : the official journal of the European Haematology Association.
[247] C. Decarli,et al. Cerebrospinal fluid viral load is related to cortical atrophy and not to intracerebral calcifications in children with symptomatic HIV disease. , 2000, Journal of neurovirology.
[248] B. Peterlin,et al. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. , 2000, Immunity.
[249] S. Lipton. Neuronal injury associated with HIV-1: approaches to treatment. , 1998, Annual review of pharmacology and toxicology.
[250] J. Busciglio,et al. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. , 1998, Journal of neurovirology.
[251] L. Epstein,et al. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. , 1997, Journal of neurovirology.
[252] A. Nath,et al. Molecular Determinants for Cellular Uptake of Tat Protein of Human Immunodeficiency Virus Type 1 in Brain Cells , 1996 .
[253] S. Perry,et al. Tumor Necrosis Factor (cid:97) Inhibits Glutamate Uptake by Primary Human Astrocytes FOR PATHOGENESIS OF HIV-1 , 2022 .
[254] H. Ushijima,et al. Neurotoxicity in rat cortical cells caused by N-methyl-D-aspartate (NMDA) and gp120 of HIV-1: induction and pharmacological intervention. , 1996, Progress in molecular and subcellular biology.
[255] C. Petito,et al. Evidence of apoptotic cell death in HIV encephalitis. , 1995, The American journal of pathology.
[256] H. Gendelman,et al. An experimental model system for HIV-1-induced brain injury. , 1994, Advances in neuroimmunology.
[257] D. Diloreto,et al. Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. , 1993, Developmental neuroscience.
[258] V. Georgiev. Virology , 1955, Nature.